Skip to main content

Abstract

The diagnostic category of “organic disorders” was officially removed from the psychiatric nosology in DSM-IV, published in 1994. Despite this change, physicians continue to use the term “organic causes” to refer to medical and neurological causes of psychiatric symptoms, and it remains part of the ICD-10 classification. In the context of increasing integration of psychiatric disorders within a medical and neuroscientific framework, the reasons behind the ongoing use of this term (reminiscent of mind-body dualism) have to be clarified. The authors conducted a survey of 391 Canadian psychiatrists and psychiatric residents to understand attitudes and beliefs related to this terminology and then applied qualitative and quantitative analyses. Results showed that the terminology is used by the majority (55.9%) of psychiatrists and residents for two main reasons: out of a habit that begins in residency training and because of the belief that other specialties do not fully understand alternative terminology. The authors found that some psychiatrists are concerned that their patients will not receive adequate investigation unless it is made clear through use of the “organic cause” term that other medical causes of psychiatric symptoms are suspected. Use of the “organic cause” term was predicted by being of younger age, performing emergency department calls, and finding alternative terminology difficult to use. These findings highlight the importance of reflecting on and discussing the effect of this terminology used in psychiatry.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 57 - 64
PubMed: 30305004

History

Received: 4 May 2018
Revision received: 23 May 2018
Accepted: 27 May 2018
Published online: 11 October 2018
Published in print: Winter 2019

Keywords

  1. Organic Mental Disorders
  2. Diagnosis and Classification in Neuropsychiatry

Authors

Details

David Benrimoh, M.D., M.Sc.
From the Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Quebec, Canada (DB, VJP, SD); the Department of Psychiatry and Addiction, Faculty of Medicine, Université de Montréal (JB); the Research Centre, Montreal Heart Institute and Université de Montréal (JB); the Department of Psychiatry, Université Laval, Quebec (SP); the Department of Nursing, University of Sherbrooke, Longueuil, Quebec (AD); the Department of Psychiatry, Université de Sherbrooke, Sherbrooke, Quebec (J-RM); and the McConnell Brain Imaging Centre, Montreal Neurological Institute (SD).
Vincent Jetté Pomerleau, M.D., M.Sc.
From the Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Quebec, Canada (DB, VJP, SD); the Department of Psychiatry and Addiction, Faculty of Medicine, Université de Montréal (JB); the Research Centre, Montreal Heart Institute and Université de Montréal (JB); the Department of Psychiatry, Université Laval, Quebec (SP); the Department of Nursing, University of Sherbrooke, Longueuil, Quebec (AD); the Department of Psychiatry, Université de Sherbrooke, Sherbrooke, Quebec (J-RM); and the McConnell Brain Imaging Centre, Montreal Neurological Institute (SD).
Arnaud Demoustier, Inf.
From the Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Quebec, Canada (DB, VJP, SD); the Department of Psychiatry and Addiction, Faculty of Medicine, Université de Montréal (JB); the Research Centre, Montreal Heart Institute and Université de Montréal (JB); the Department of Psychiatry, Université Laval, Quebec (SP); the Department of Nursing, University of Sherbrooke, Longueuil, Quebec (AD); the Department of Psychiatry, Université de Sherbrooke, Sherbrooke, Quebec (J-RM); and the McConnell Brain Imaging Centre, Montreal Neurological Institute (SD).
Stéphane Poulin, M.D.
From the Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Quebec, Canada (DB, VJP, SD); the Department of Psychiatry and Addiction, Faculty of Medicine, Université de Montréal (JB); the Research Centre, Montreal Heart Institute and Université de Montréal (JB); the Department of Psychiatry, Université Laval, Quebec (SP); the Department of Nursing, University of Sherbrooke, Longueuil, Quebec (AD); the Department of Psychiatry, Université de Sherbrooke, Sherbrooke, Quebec (J-RM); and the McConnell Brain Imaging Centre, Montreal Neurological Institute (SD).
Jean-Robert Maltais, M.D.
From the Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Quebec, Canada (DB, VJP, SD); the Department of Psychiatry and Addiction, Faculty of Medicine, Université de Montréal (JB); the Research Centre, Montreal Heart Institute and Université de Montréal (JB); the Department of Psychiatry, Université Laval, Quebec (SP); the Department of Nursing, University of Sherbrooke, Longueuil, Quebec (AD); the Department of Psychiatry, Université de Sherbrooke, Sherbrooke, Quebec (J-RM); and the McConnell Brain Imaging Centre, Montreal Neurological Institute (SD).
Judith Brouillette, M.D., Ph.D.
From the Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Quebec, Canada (DB, VJP, SD); the Department of Psychiatry and Addiction, Faculty of Medicine, Université de Montréal (JB); the Research Centre, Montreal Heart Institute and Université de Montréal (JB); the Department of Psychiatry, Université Laval, Quebec (SP); the Department of Nursing, University of Sherbrooke, Longueuil, Quebec (AD); the Department of Psychiatry, Université de Sherbrooke, Sherbrooke, Quebec (J-RM); and the McConnell Brain Imaging Centre, Montreal Neurological Institute (SD).
Simon Ducharme, M.D., M.Sc. [email protected]
From the Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Quebec, Canada (DB, VJP, SD); the Department of Psychiatry and Addiction, Faculty of Medicine, Université de Montréal (JB); the Research Centre, Montreal Heart Institute and Université de Montréal (JB); the Department of Psychiatry, Université Laval, Quebec (SP); the Department of Nursing, University of Sherbrooke, Longueuil, Quebec (AD); the Department of Psychiatry, Université de Sherbrooke, Sherbrooke, Quebec (J-RM); and the McConnell Brain Imaging Centre, Montreal Neurological Institute (SD).

Notes

Send correspondence to Dr. Ducharme; e-mail: [email protected]

Competing Interests

Dr. Benrimoh receives research funding from the Richard and Edith Strauss Clinical Fellowship and the Fonds de Recherche du Québec-Santé; and he is CEO, shareholder, and board member of Aifred Health. Mr. Demoustier receives funding from Société des Médecins de l’Université de Sherbrooke and Instituts de recherche en santé du Canada. Dr. Ducharme receives salary funding from the Fonds de Recherche du Québec-Santé. All other authors report no financial relationships with commercial interests.

Funding Information

Fonds de Recherche du Québec - Santé10.13039/501100000156:
Richard and Edith Strauss Fellowship:

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share